Pharmaghreb

Having obtained its first marketing authorization in 1989, PHARMAGHREB has continued to evolve, reaching more than 30 years of experience and more than 120 finished products spanning several therapeutic areas. The company manufactures its own generic drugs, products under license from internationally renowned donors, and subcontracted products, with laboratories equipped with cutting-edge technology to manufacture liquids (solutions, syrups, suspensions), semi-solids (gels, ointments, suppositories) and dry forms (tablets, capsules, sachets, powders).